Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook

Colon Cancer

Colon cancer patient using vectibix

09/06/2007

Question:

What is their survival rate after eleven months of chemo and no other options but vextibix.

Answer:

It is difficult to answer without knowing more details. But in patients who failed multiple therapies and got vectibix only, average survival is less than 6 months.

For more information:

Go to the Colon Cancer health topic, where you can:

Response by:

Malek  Safa, MD Malek Safa, MD
Assistant Professor of Medicine
College of Medicine
University of Cincinnati